By Matt Jones

NEW YORK (GenomeWeb News) –The Supreme Court of the United States on Friday began considering whether to take up the case between Myriad Genetics, the Association of American Pathology, and other plaintiffs and defendants that could either shore up or change current US laws covering gene patenting.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.